TECH vs XRAY · P/E 65, rev $1.22B vs rev $3.68B
Bio-Techne Corp (TECH) versus Dentsply Sirona Inc (XRAY) — a side-by-side from cached financials, not a winner call.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Dentsply Sirona Inc (XRAY) is a medical instruments & supplies company listed on NASDAQ.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Latest reported XRAY revenue for 2025-12-31 was $3.68B. Net income was -$598.0M. Revenue was down 3.0% from 2024-12-31 to 2025-12-31. XRAY currently screens at market cap $2.01B.
TECH currently screens at market cap $8.49B and trailing P/E 65.2. XRAY currently screens at market cap $2.01B.
Not investment advice. Open the TECH and XRAY stock pages for the full models.
Not investment advice.